A Prospective Study to Analyse the Metabolic Effect of Metformin with Glimepiride on Type 2 Diabetic Patients of North India.

Simple item page
dc.contributor.authorSingh, Preeti
dc.contributor.authorKhan, Farhan Ahmad
dc.contributor.authorHemnani, T J
dc.contributor.authorMatreja, Prithpal S
dc.contributor.authorSingh, V K
dc.date.accessioned2016-10-13T06:34:08Z
dc.date.available2016-10-13T06:34:08Z
dc.date.issued2016-07
dc.description.abstractBackground: Diabetes Mellitus is a leading disease of developing countries and its incidence is increasing day by day. Among Oral Hypoglycemic agents, Metformin is still the best treatment choice for type 2 diabetes mellitus. Metformin is associated with improvements in lipoprotein metabolism, including decreases in LDL-C, fasting and postprandial TGs, and free fatty acids. Methods: This prospective study was carried out on Type 2 Diabetic patients attending the Diabetic clinic at Teerthanker Mahaveer Medical College & Research Center, Moradabad. Only those patients were included who were not adequately controlled with a stable dose of metformin monotherapy. A total of 125 patients were enrolled in the study taking Glimepiride plus Metformin. The patients received therapy of metformin 500mg three times daily & glimepiride 5mg twice daily. Results: Out of the 125 patients enrolled in the study, only 82 patients completed the study. Out of 82 patients, 49 were males and 33 females. There was a significant reduction (p<0.05) of FPG as compared to baseline. The (PPBS) was reduced from 275.95 ±63.599 (mg/dl) to 167.04±27.084 (mg/dl) at 12 weeks and141.36±31.064(mg/dl) at 24 weeks (mg/dl). There was a significant reduction (p<0.05) of Hb1Ac, TC, TAG, LDL, VLDL, UA, SGOT as compared to baseline but no significant rise in HDL was seen as compared to baseline. Conclusion: Significant improvement in fasting blood sugar (FBS), Postprandial blood sugar (PPBS), Lipid profile and Glycosylated hemoglobin as compared to baseline.en_US
dc.identifier.citationSingh Preeti, Khan Farhan Ahmad, Hemnani T J, Matreja Prithpal S, Singh V K. A Prospective Study to Analyse the Metabolic Effect of Metformin with Glimepiride on Type 2 Diabetic Patients of North India. Annals of International Medical and Dental Research. 2016 July-Aug; 2(4): 242-245.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/177765
dc.language.isoenen_US
dc.source.urihttps://aimdrjournal.com/pdf/Vol2Issue4_59_OA.pdfen_US
dc.subjectGlimepirideen_US
dc.subjectMetforminen_US
dc.subjectType 2 Diabetes Mellitusen_US
dc.subjectMetabolic Syndromeen_US
dc.titleA Prospective Study to Analyse the Metabolic Effect of Metformin with Glimepiride on Type 2 Diabetic Patients of North India.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
aimdr2016v2n4p242.pdf
Size:
93.05 KB
Format:
Adobe Portable Document Format
Description:
Original article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Annals of International Medical and Dental Research